National Health Act 1953 - Determination under subsection 99(4) (16/07/1996)

Overview

The National Health Act 1953 was enacted to provide a framework for the administration of health services in Australia, particularly focusing on the provision of medical services and benefits. This Act was introduced to address the need for a coordinated approach to healthcare funding and services across the nation. The legislation aims to ensure that Australians have access to essential health services, including pharmaceuticals, through a system of payments and benefits. The National Health Act 1953 empowers the Commonwealth to make determinations regarding the provision of pharmaceutical benefits, which are crucial for managing the costs of medications and ensuring equitable access for patients. This legislative instrument, specifically the Pharmaceutical Benefits Determination, was made under subsection 99 (4) of the Act by David Trevor Graham, the Assistant Secretary of the Pharmaceutical Benefits Branch in the Department of Health and Family Services, acting as the delegate of the Minister for Health and Family Services. The policy objective behind this determination is to establish the rates and conditions for Commonwealth payments to approved private hospitals for the supply of pharmaceutical benefits, thereby ensuring that patients receive necessary medications at a regulated cost.

Scope and Application

The Pharmaceutical Benefits Determination under subsection 99 (4) of the National Health Act 1953 applies to approved private hospitals and the patients they treat. This legislation sets out the rates at which the Commonwealth will reimburse approved private hospitals for the supply of pharmaceutical benefits to patients, including those who are inpatients or outpatients. The rates of payment are determined by the Commonwealth price for the pharmaceutical benefits, which is ascertained according to the determination under paragraph 98B (1) (a) of the Act. The conditions governing the supply of pharmaceutical benefits to patients in private hospitals are the same as those that apply to approved pharmacists and medical practitioners, as outlined in paragraph 98C (1) (b) of the Act. This Determination revokes a previous determination made on 18 July 1991, and came into effect on 1 August 1996. The scope of the Act is national, applying across the Commonwealth of Australia, and its application may be extended or restricted through subordinate instruments.

Key Provisions

This Determination under the National Health Act 1953 sets out the terms for pharmaceutical benefits provided to patients in approved private hospitals. Effective from 1 August 1996, the Determination replaces a previous version from 1991. It defines "patient" as either an in-patient, who occupies a hospital bed for treatment, or an out-patient, who is registered for treatment at the hospital but not admitted to a bed (Section 3). The payment for pharmaceutical benefits supplied to patients in these hospitals will be based on the Commonwealth price determined under section 98B(1)(a) of the National Health Act 1953, effective at the time of supply (Section 4). Furthermore, payments for these benefits must adhere to the same conditions that apply to supplies by approved pharmacists or medical practitioners, as outlined in section 98C(1)(b) of the Act (Section 5). The obligations imposed by this Determination include ensuring that the pharmaceutical benefits provided to patients in approved private hospitals are compensated at the correct rate, as determined by the Commonwealth price at the time of supply. The payments must also comply with conditions applicable to supplies by approved pharmacists or medical practitioners. Hospitals must ensure they are registered and approved under the Act to be eligible for these payments. Breaching the provisions of this Determination could result in legal consequences. While the Determination itself does not specify explicit penalties for non-compliance, breaches of the National Health Act 1953 generally can lead to both civil and criminal penalties. Civil penalties can include fines, and in severe cases, criminal penalties might apply, including imprisonment. The specific penalties depend on the nature and severity of the breach, as outlined in the broader provisions of the National Health Act 1953.